The short version
12 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE · ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 · Tablet, Coated · Oral · Retail Business Services , Llc.
NDC 72476-0120-06 · 2 BLISTER PACK in 1 CARTON / 12 TABLET, COATED in 1 BLISTER PACK · OTC MONOGRAPH DRUG · View full market →
12 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market · price up 2% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Discount Drug Mart | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Harris Teeter | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Hyvee Inc | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| AAA Pharmaceutical, Inc. | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Marketing Association Inc | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Marketing Association, Inc. | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Topcare | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Topco Associates Llc | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Valu Merchandisers Company | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Goodsense | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Retail Business Services , Llc. | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Marc Glassman, Inc. | ACETAMINOPHEN 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Sinus Pressure plus Pain PE — NDC 72476-0120-06," retrieved September 3, 2026, https://drugdashboards.com/drug/72476012006.
Free to cite with attribution — see how the data is put together.